Chemomab Therapeutics Ltd. Cash And Cash Equivalents
Chemomab Therapeutics Ltd. (CMMB) had Cash And Cash Equivalents of $7.52 million as of 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
ifrs-full:CashAndCashEquivalents · last filed 2019-04-24
- 2018-12-31: Cash And Cash Equivalents $7.52M.
- 2017-12-31: Cash And Cash Equivalents $1.45M.
- 2016-12-31: Cash And Cash Equivalents $4.56M.
- 2015-12-31: Cash And Cash Equivalents $2.20M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2018-12-31 | $7.52M 20-F · filed 2019-04-24 |
| 2017-12-31 | $1.45M 20-F · filed 2019-04-24 |
| 2016-12-31 | $4.56M 20-F · filed 2019-04-24 |
| 2015-12-31 | $2.20M 20-F · filed 2019-04-24 |